4//SEC Filing
NAGJI BANSI 4
Accession 0000899243-21-039976
CIK 0001809519other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 9:32 PM ET
Size
9.7 KB
Accession
0000899243-21-039976
Insider Transaction Report
Form 4
Nagji Bansi
President, Healthcare
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-10-07−3,600→ 3,600 totalExercise: $6.84Exp: 2030-06-15→ Class A Common Stock (3,600 underlying) - Exercise/Conversion
Class A Common Stock
2021-10-07$6.84/sh+3,600$24,624→ 32,766 total - Sale
Class A Common Stock
2021-10-07$45.05/sh−3,600$162,187→ 29,166 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024.
- [F4]The Reporting Person's prior Form 4 filed on September 16, 2021 incorrectly stated that 309,564 shares underlying this option remained after the reported transactions and should have reported 309,584 shares underlying this option after the reported transactions.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001632311
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 9:32 PM ET
- Size
- 9.7 KB